{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009828","form_type":"8-K","ticker":"CARL","cik":"0001794546","company_name":"CARLSMED, INC.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.199283+00:00","generated_at":"2026-05-16T10:55:10.202880+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Carlsmed reports Q4 revenue ~$15.2M (+61% YoY); FY2025 ~$50.5M (+86% YoY)","bullets":["Preliminary Q4 2025 revenue of ~$15.2M, 61% increase over Q4 2024.","Full-year 2025 revenue of ~$50.5M, 86% increase over 2024.","Added 101 new surgeon users in 2025, a 61% increase in user base.","Launched aprevo® cervical; early surgeon feedback encouraging.","CEO cites transformational year; company focused on operational excellence for 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009828","json":"https://secwatch.observer/filing/0001193125-26-009828.json","markdown":"https://secwatch.observer/filing/0001193125-26-009828.md","text":"https://secwatch.observer/filing/0001193125-26-009828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1794546/000119312526009828/0001193125-26-009828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1794546/000119312526009828/carl-20260112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:55:10.202880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}